Literature DB >> 8620510

Distal nephron renal tumors: microsatellite allelotype.

T J Polascik1, P Cairns, J I Epstein, L Fuzesi, J Y Ro, F F Marshall, D Sidransky, M Schoenberg.   

Abstract

Tumors of varying malignant potential arise from the complex epithelial lining of the nephron. Although the molecular characteristics of renal clear cell carcinomas, which arise from the proximal tubule, have been studied, little is known about tumors that develop from other parts of the renal tubular system. To elucidate common molecular lesions that may contribute to the development or progression of nonproximal tubule renal tumors, we performed a detailed microsatellite allelotype of lesions thought to arise from the renal collecting duct. Eighteen collecting duct carcinomas (CDCs) and 13 renal oncocytomas were studied using highly informative microsatellite markers on all autosomal arms. Loss of heterozygosity (LOH) was identified on multiple chromosomal arms in CDCs and renal oncocytomas. Microsatellite analysis revealed LOH of 1q in 57% of informative CDCs. LOH was also observed on arms 6p (45%), 8p (40%), and 21q (40%). In renal oncocytomas, LOH of 1q occurred in approximately 30% of tumors, but 1p LOH was observed in 57% of informative cases analyzed. High levels of LOH were also observed on arms 8p, 14q, 19q, and 21q in the oncocytomas studied. Loss of chromosomal arm 3p was infrequent in both tumor types. Our results suggest that the molecular events that contribute to the development of distal nephron tumors are distinct from those associated with the etiology of proximal tubule renal cancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620510

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Collecting (Bellini) duct carcinoma of the kidney--clinical, radiologic and immunohistochemical findings.

Authors:  P Dobroński; M Czaplicki; E Koźmińska; R Pykało
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 2.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 3.  Signaling pathways in renal cell carcinoma.

Authors:  Gowrishankar Banumathy; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

Review 4.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

5.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

Authors:  P Bugert; G Kovacs
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 6.  Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.

Authors:  G Steiner; D Sidransky
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

7.  MET expression in sporadic renal cell carcinomas.

Authors:  Jong Sun Choi; Mi-Kyung Kim; Jin Won Seo; Yoon-La Choi; Dong Hoon Kim; Yi Kyeong Chun; Young Hyeh Ko
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

8.  Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q.

Authors:  A Schwendel; F Richard; H Langreck; O Kaufmann; H Lage; K J Winzer; I Petersen; M Dietel
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.